News

Your contact person

Manager PR & Communications Jan Phillip Denkers

At the end of September, researchers and other stakeholders from the HALRIC network met in Hamburg to plan and discuss future collaborations. (Picture: UHH/Feurerböter)
At the end of September, researchers and other stakeholders from the HALRIC network met in Hamburg to plan and discuss future collaborations. (Picture: UHH/Feurerböter)

HALRIC gathers 100 people in Hamburg

On 24-25 September over 100 people attended HALRIC’s conference at the Bahrenfeld Campus in Hamburg. The first day kicked off with a high-level panel session, ...

Read more …
Left to right: Dr. Erik Bogsch, Daniel Ambrock, Daniel Günther, Dr. Kai Pohlmeyer, Erik Bogsch
Left to right: Dr. Erik Bogsch – Head of the Biotechnology Business Unit, Daniel Ambrock - Mayor of Bovenau, Daniel Günther - Minister-President of the State of Schleswig-Holstein, Dr. Kai Pohlmeyer - CEO, Erik Bogsch – Lifetime Honorary Chairman (Picture: Richter BioLogics)

Richter BioLogics triples production capacity

Richter BioLogics GmbH & Co KG, the microbial biologics affiliate of Gedeon Richter Plc. celebrated the opening of ...

Read more …
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients.
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients. (Image: Screenshot/Discover Oncology)

Indivumed: New Publication in Discover Oncology

Indivumed GmbH announced the fourth research publication enabled by the Indivumed Omics Hub. An interface for members of the Indivumed Global Clinical Network, the Omics ...

Read more …
Hans Kuhn hands over responsibilities to his successors Mariela Aranda (left) and Julianna Shibao (right).
Hans Kuhn hands over responsibilities to his successors Mariela Aranda (left) and Julianna Shibao (right). (Picture: altona Diagnostics)

New management at altona Diagnostics in Argentina and Brazil

After more than six years at the helm of the Argentine and Brazilian subsidiaries of altona Diagnostics based in Buenos ...

Read more …
3D vector field of the collagen direction and degree of orientation obtained by SAXS-Tensor-Tomography (Picture: DESY)
3D vector field of the collagen direction and degree of orientation obtained by SAXS-Tensor-Tomography (Picture: DESY)

Deeper Insights in Breast Cancer Metastasis

A collaborative effort between researchers from DESY, the University Medical Center Hamburg-Eppendorf (UKE), ...

Read more …
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)

SurgMark: FDA 510(k) Clearance for SchurSign Tissue Marker

In January SurgMark GmbH announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for ...

Read more …
The Stentrode™ Endovascular Electrode Array (Photo: Synchron)
The Stentrode™ Endovascular Electrode Array (Photo: Synchron)

Synchron Acquires Equity Stake in ACQUANDAS

Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the acquisition of an equity stake ...

Read more …
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)

"Stealth Effect"

An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...

Read more …
Evotec has started the search for a permanent solution for the position of CEO.

Evotec announces CEO transition

Evotec SE announced that after close to 15 years of successful service, CEO Dr Werner Lanthaler has informed the company, that he will not continue ...

Read more …
Prof. Thomas Feurer, Copyright: private
Prof. Thomas Feurer, Copyright: private

European XFEL: New Chairman of the Management Board

Physicist Prof Thomas Feurer has assumed the role of the new Chairman of the European XFEL Management Board on 1 January. Hailing from the University ...

Read more …